The decrease in RNF8 expression resulted in reduced ubiquitination of L3MBTL1 following Osimertinib treatment, allowing the expression of L3MBTL1 protein to remain stable in Osimertinib-resistant NSCLC cells. Here, RNF8 is linked to non-small cell lung carcinoma.